Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2025-01-27 Regulatory Filings
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Progress in the MDR process - aap receives MDR certificate
Regulatory Filings Classification · 100% confidence The document is a short news release dated January 27, 2025, announcing that 'aap Implantate AG... received the MDR certificate for its quality system'. It uses keywords like 'EQS-News', 'Regulatory Approval/Miscellaneous', and discusses a specific regulatory milestone (MDR certification). The length is relatively short (5188 characters) and it functions as an announcement of an event/approval rather than a comprehensive report (like 10-K or IR). Since it is a specific regulatory update that doesn't fit perfectly into the defined categories like 'Audit Report (AR)' or 'Legal Proceedings (LTR)', and it is a general regulatory announcement disseminated via EQS, the most appropriate fallback category is 'Regulatory Filings (RNS)'. It is not an Earnings Release (ER) or a Report Publication Announcement (RPA) because it is announcing a specific regulatory achievement, not the publication of a financial report.
2025-01-27 English
Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%)
Earnings Release Classification · 100% confidence The document is a news release dated January 24, 2025, announcing preliminary sales results for the fiscal year 2024. It contains key financial highlights (annual sales of EUR 12.2 million, +6%) and operational updates. Crucially, it explicitly states: "The company will provide information on the outlook for the 2025 financial year and the management agenda in a separate announcement," and "*aap* plans to announce the final, audited results for the financial year 2024 at the end of April as part of the consolidated annual financial report 2024." This structure—providing preliminary figures and announcing a future, more comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but the initial announcement of period results. FY 2024
2025-01-25 English
Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%)
Earnings Release Classification · 100% confidence The document is a news release dated January 24, 2025, announcing preliminary sales results for the fiscal year 2024. It contains key financial highlights (annual sales of EUR 12.2 million, +6%) and operational updates. Crucially, it explicitly states: "The company will provide information on the outlook for the 2025 financial year and the management agenda in a separate announcement," and "*aap* plans to announce the final, audited results for the financial year 2024 at the end of April as part of the consolidated annual financial report 2024." This structure—providing preliminary figures and announcing a future, more comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but the initial announcement of period results. FY 2024
2025-01-24 English
aap Implantate AG: Merval AG, Purchase of shares through the exercise of conversion rights
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section detailing 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It lists the name of the associated person (Nathalie Krebs, Member of the administrative or supervisory body) and details a 'Purchase of shares through the exercise of conversion rights' by Merval AG. This content directly matches the definition for Director's Dealing reports.
2024-12-18 English
aap Implantate AG: Merval AG, Subscription of shares as part of a private placement in connection with a capital increase with exclusion of subscription rights
Director's Dealing Classification · 99% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section detailing 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It lists the name of a person closely associated with management (Nathalie Krebs, Member of the administrative or supervisory body) and details a transaction involving the subscription of shares. This directly matches the definition for Director's Dealing (DIRS). Although the transaction involves a capital increase, the primary focus and reporting requirement being fulfilled here is the insider transaction disclosure.
2024-12-17 English
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 15.01.2025 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is explicitly titled "Bekanntmachung der Einberufung zur Hauptversammlung am 15.01.2025" (Announcement of the convocation to the Annual General Meeting on 15.01.2025). It contains a detailed agenda (Tagesordnung) for the upcoming General Meeting, including items like voting on the discharge of the board and supervisory board, and discussion of the remuneration report (§ 162 AktG). This content is characteristic of materials related to an Annual General Meeting (AGM) or the preceding proxy/information statement. Since the document is the formal invitation/convocation notice itself, and it discusses items that will be voted upon or presented at the AGM, the most fitting category is AGM Information (AGM-R). While it discusses the remuneration report (which relates to DEF 14A), the primary purpose of this specific document is the formal convening of the AGM.
2024-12-10 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.